×

CancerSites icon
Apk

CancerSites

Developed by Jefferson University

CancerSites APK for Android

CancerSites is a free Android™ medical app. Download CancerSites APK direct installer latest version updated by Jefferson University original developer. Please verify that it is the correct CancerSites developer, do not forget to read the premium antivirus report before downloading.

Votes: 1
Rating: 5.0/5

good bad

  • APK Name: CancerSites
  • Category: Android Apps
  • Subcategory: Medical
  • Package Name : edu.jefferson.patientsbookmarks
  • Version: 0.0.2 for Android Min SDK Gingerbread 2.3.3-7
  • Developer: Jefferson University
  • Signature: ✓ 6C3F2C2F50FE7E258E9675B307C1D4CE978F1B4C
  • Language: English and others
  • File Size: 2.4MB
  • Google Play Store: Not found
Marvelo

Marvelo APK

2.7MB 1.3.0

MoveOn AR

MoveOn AR APK

22.5MB 1.0

CBall

CBall APK

20.5MB 1.0

MatchCalcer

MatchCalcer APK

413KB 1.001

Fleksy

Fleksy APK

15.8MB 6.1.9

Vision

Vision APK

21.4MB 1.2.5

CancerSites APK Download

We offer an easy and faster apk download, a complete information about the CancerSites APK file you are downloading is provided before you download. The first thing you have to read is the antivirus report, given by more than 50 trusted and recognized antivirus, followed is to verify if the apk developer is the one you are looking for, in many cases the apps or games may have the same name but not be the correct developer.

You can also find latest CancerSites Apk versions available and system requirement needed to install it, and more technical information about the Apk file, you can download the apk installer for free, without packed, wrapped or any modification, apk file contain the signature of the official developers. You could also download CancerSites from another alternative website or from the official Android app stores like Google Play Store or Amazon Appstore, but maybe some apps or games could be not available there.

Apk Free Download Cookies Policy DMCA Statement Contact Us

apkfree.com © 2024